Experimental Drug Fails Phase Three Lung-Cancer Study
Links shared publicly online about this topic
Pfizer Disappointed by Study Results - WSJ.com
online.wsj.com — “Pfizer ended a Phase III trial for its experimental lung-cancer drug and said two studies of its advanced breast-cancer drug failed to meet their primary endpoints.” View full resource at online.wsj.com
Most Recently Shared on March 13, 2010 at 12:53 am By:
DrEliaz CAM, Integrative Physician, Physician, Acupuncturist, and Doctor
WSJ.com - Pfizer Disappointed in Study Results for Two Drugs http://on.wsj.com/aMMI9y
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
DrEliaz
Integrative, Holistic MD. Acupuncturist. I treat the whole person, physically & spiritually. Integrative Medicine, Functional Medicine. youtube.com/dreliaz
Advertisement
